Precision Medicine

ING5 Regulates Lung Cancer Metabolism via PDK1 Phosphorylation
Research & Development ING5 Regulates Lung Cancer Metabolism via PDK1 Phosphorylation

Lung cancer remains a formidable foe in the realm of oncology, claiming more lives than any other cancer worldwide due to its high rate of metastasis. One of the critical factors contributing to lung cancer's aggressiveness is the Warburg effect, where cancer cells favor aerobic glycolysis over

Can Gene Therapy Improve Kidney Disease Treatment with AAV Vectors?
Tech & Innovation Can Gene Therapy Improve Kidney Disease Treatment with AAV Vectors?

Gene therapy has emerged as a promising frontier for treating a range of genetic disorders, but effectively delivering therapeutic genes to the kidneys remains a significant challenge. Researchers at the Oregon Health & Science University School of Medicine have been delving into the complex domain

Can CDKN2A Mutations Be Both Protective and Harmful in Esophageal Cancer?
Research & Development Can CDKN2A Mutations Be Both Protective and Harmful in Esophageal Cancer?

Recent groundbreaking research on genetic mutations in esophageal cancer has revealed surprising insights into the role of the CDKN2A gene. Traditionally seen as a driver of cancer development, this gene might also play a protective role in the early stages of esophageal cancer. This discovery

Can Tumor Organoids From Blood Samples Transform Breast Cancer Treatment?
Research & Development Can Tumor Organoids From Blood Samples Transform Breast Cancer Treatment?

A significant breakthrough by researchers from the German Cancer Research Center (DKFZ), Heidelberg Stem Cell Institute (HI-STEM), and NCT Heidelberg in addressing breast cancer metastasis has the potential to revolutionize treatment approaches. Metastases to vital organs like the liver, lungs, or

Takeda Advances Psoriasis Treatment with Oral TYK2 Inhibitor TAK-279
Research & Development Takeda Advances Psoriasis Treatment with Oral TYK2 Inhibitor TAK-279

Psoriasis, often misunderstood as merely a skin condition, is a complex immune-mediated disease impacting around 125 million individuals globally. This systemic condition demands comprehensive treatment strategies that go beyond addressing superficial skin symptoms. Dr. Graham Heap, Vice President

Can Large-Scale Genomic Profiling Revolutionize Cancer Treatment?
Tech & Innovation Can Large-Scale Genomic Profiling Revolutionize Cancer Treatment?

Recent advancements in genomic analysis have demonstrated significant potential to improve outcomes for patients across a wide spectrum of cancer types. A large-scale study conducted by researchers from Genentech and Stanford University analyzed nearly 80,000 U.S. cancer patients to uncover 776

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later